Cancer stem cell markers in lung cancer[J] . Takeaki Miyata,Takashi Yoshimatsu,Tetsuya So,Tsunehiro Oyama,Hidetaka Uramoto,Toshihiro Osaki,Ryoichi Nakanishi,Fumihiro Tanaka,Hisao Nagaya,Akinobu Gotoh.Personalized Medicine Universe . 2015Miyata T, Yoshimatsu T, So T, et 01. Cancer stem cell mark-...
Publication » CD90 (thy1) As A Potential Cancer Stem Cell Markers And Therapeutic Target In Non-Small Cell Lung Cancer. MK Jacob,H Male,EB Diaz,... - American Thoracic Society International Conference 被引量: 1发表: 2011年 Cancer Stem Cells, Epithelial to Mesenchymal Markers, and Circulat...
The ALDH1-positive cancer cells they isolated exhibited several of the important CSC properties: self-renewal, differentiation, multidrug resistance and expression of stem cell marker in vitro; tumor initiation and occurrence of a heterogeneous population of cancer cells in vivo. Jiang et al. also ...
Of the many markers for cancer stem cells (CSCs) in lung cancer reported to date, the cell surface antigen CD133, nuclear β-catenin accumulation, the side population phenotype, and high aldehyde dehydrogenase (ALDH) activity seem to be most reliable. In this chapter, we review the results ...
Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug deli... A wide range of anti-cancer drugs are substrates of the ATP-binding cassette transporter ABCG2/CD338/BCRP/MXR, which is thought to play...
Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Non-small Cell Lung Cancer:a Systematic Review Prognostic Value of Cancer Stem Cell Marker CD133 Expression in Non-small Cell Lung Cancer:a Systematic ReviewObjective;To investigate the correlation between... 瞿红英,罗荣城,张军一,.....
Objective To investigate the expression and significance of cancer stem cell markers CD133,ABCG2 and p75NTR in non-small cell lung carcinoma(NSCLC).Methods Forty-four cases of NSCLC tissues were detected by immunohistochemistry for CD133,ABCG2 and p75NTR.Results(1) The expression rate of CD133...
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer Tumor contains small population of cancer stem cells (CSC) that are responsible for its maintenance and relapse. Analysis of these CSCs may lead to effecti... F Jiang,Q Qiu,A Khanna,... - 《Molecular Cancer Res...
Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121, 823–835 (2005). This study was the first to characterize a bipotent cell type in the distal lung, termed the BASC. Importantly, the BASCs were shown to expand in response to oncogenic KRAS activation,...
Lung cancer is the leading cause of cancer-related mortality, and new therapeutic options are urgently needed. Non-small cell lung cancer (NSCLC) accounts for approximately 85 % of all lung cancers, with the current standard regimen of care for NSCLC including chemotherapy with pemetrexed as a ...